INTRODUCTION
Contributed by: Nicola Dagg, Daniel Lim, Jin Ooi and Alex Magnusdottir, Kirkland & Ellis International LLP
Kirkland & Ellis International LLP has a patent litigation practice comprised of approximately 230 attorneys in London, Austin, Boston, Chi- cago, Houston, Los Angeles, New York, Palo Alto, Salt Lake City, San Francisco and Wash - ington, DC. More than 75% of Kirkland’s pat - ent litigation attorneys are engineers and scien - tists, trained in a variety of technical disciplines. Kirkland’s experienced IP litigation attorneys achieve extraordinary results in patent, copy - right, trade mark, trade secret misappropriation and advertising matters. They represent clients across a broad range of industries, including
life sciences, technology, consumer products manufacturing, financial services, automotive, and food and beverage. Other areas of prac - tice are pharmaceutical and biologics patent litigation, co-ordinating global IP enforcement/ defence cases, SEPs and FRAND disputes, post-grant proceedings before the US Patent and Trademark Office’s Patent Trial and Appeal Board, and appeals of high-stakes cases in the US Court of Appeals for the Federal Circuit and the US Supreme Court, as well as the Court of Appeal of England and Wales and the UK Su - preme Court.
Contributing Editor
Co-Authors
Nicola Dagg is a partner and leader of Kirkland’s IP litigation practice in London. She draws upon experience of more than 25 years at the forefront of IP litigation, particularly in relation
Daniel Lim is a partner in Kirkland & Ellis International LLP’s IP litigation practice in London, where he focuses on high-stakes life sciences patent litigation – particularly with
to trade secrets and patents. Her practice includes pharmaceutical and biologics patent litigation; strategic life sciences patent and product life cycle advice; co-ordinating global IP enforcement/defence cases; hi-tech, digital and telecommunications litigation; and SEP and FRAND disputes. Nicola, who also has an MA in natural sciences, is renowned for her strategic and creative approach to solving difficult and commercially critical IP issues and regularly represents her clients in ground- breaking cases in the Court of Appeal and UK Supreme Court.
regard to diagnostics, precision medicine, cell and gene therapy, and the pharmaceutical industry. His case experience includes oncology, molecular biology, diagnostics, antibody engineering and biostatistics, and often involves issues at the cutting edge of the law – notably in relation to second medical-use patents. He is active as a member of the International Association for the Protection of Intellectual Property (AIPPI) and the European Patent Lawyers Association (EPLAW), including as vice-chair of AIPPI’s standing committee on biotechnology.
4
CHAMBERS.COM
Powered by FlippingBook